[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346408-105":59,"doc-detail-346408-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","exploring-the-mechanism-of-oral-cancer-with-shikonin-network-pharmacology-and-molecular-docking-technology","Exploring the Mechanism of Oral Cancer With Shikonin - Network Pharmacology and Molecular Docking Technology","","Objectives: explore the underlying mechanisms of shikonin in treating oral cancer through network pharmacology and molecular docking. Materials and methods: collect shikonin targets from TCMSP, BATMAN, ChEMBL, PharmMapper and HERB; collect oral cancer targets from OMIM, STITCH, GeneCards and Drugbank; intersect targets; perform DAVID-based GO and KEGG enrichment; build a STRING PPI network and use Cytoscape to identify key genes; evaluate binding via docking and molecular dynamics. Results: screen 481 shikonin targets and 10,058 oral cancer targets; implicate apoptosis, inflammation and immune-response pathways. Conclusions: multiple molecular mechanisms of shikonin for oral cancer management are elucidated, revealing potential therapeutic targets.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-mechanism-of-oral-cancer-with-shikonin-network-pharmacology-and-molecular-docking-technology/346408/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-mechanism-of-oral-cancer-with-shikonin-network-pharmacology-and-molecular-docking-technology/346408.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the objective of the study on shikonin and oral cancer?","Question",{"text":112,"@type":113},"The study aims to explore how shikonin treats oral cancer by identifying its underlying mechanisms using network pharmacology and molecular docking.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were targets for shikonin and oral cancer collected and analyzed?",{"text":117,"@type":113},"Shikonin targets were retrieved from TCMSP, BATMAN, ChEMBL, PharmMapper and HERB, while oral cancer targets were gathered from OMIM, STITCH, GeneCards and Drugbank. Intersecting targets were then used for DAVID GO/KEGG enrichment and STRING/Cytoscape analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological processes and pathways are suggested by the enrichment and network results?",{"text":121,"@type":113},"GO/KEGG results suggest involvement in apoptosis, inflammation and immune responses, with related pathways including FoxO, HIF-1, TNF signaling and Th17 cell differentiation.",{"name":123,"@type":110,"acceptedAnswer":124},"What do docking and molecular dynamics results indicate about shikonin binding?",{"text":125,"@type":113},"Docking and molecular dynamics simulations show favorable binding interactions between shikonin and key targets, including CCL3, AKT1 and NOX1.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},346408,1790170686,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Scientiﬁc Research Report  \nExploring the Mechanism of Oral Cancer With Shikonin Based on the Network Pharmacology and Molecular Docking Technology  \nLin Houa,y, Kun Wang b,y, Yusheng Wang a, Jing Lia, Lin Guoc*, Qingliang Zhao a*  \na Department of Stomatology, Harbin the First Hospital, Harbin, Heilongjiang Province, China  \nb Department of Central Sterile Supply, the First Afﬁliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China  \nc School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China  \nA R T I C L E I N F O  \nArticle history:  \nReceived 16 May 2025  \nReceived in revised form  \n27 August 2025  \nAccepted 15 September 2025 Available online xxx  \nKey words: shikonin  \nOral squamous cell carcinoma  \nOral cancer  \nNetwork pharmacology Molecular docking  \nA B S T R A C T  \nObjectives: To explore the underlying mechanisms of shikonin in treating oral cancer using network pharmacology and molecular docking methods.  \nMaterials and methods: Targets of shikonin were obtained from the TCMSP, BATMAN, ChEMBL, PharmMapper and HERB databases. Targets of oral cancer were gathered from the OMIM, STITCH, GeneCards and Drugbank databases. The intersection targets of shikonin and oral cancer were obtained for subsequent analysis. The intersecting targets of shikonin and oral cancer were entered into the DAVID database and used its functions to perform Gene Ontology (GO) and Kyoto encyclopaedia of genes and genomes (KEGG) enrichment analysis on the intersection targets to obtain the relevant pathways and biological functions of shikonin in the treatment of oral cancer. The protein-protein interaction (PPI) network of shikonin and oral cancer targets was constructed in STRING platform. Subsequently, using Cytoscape 3.8.0 to obtain the key targets of shikonin and oral cancer. Finally, molecular docking and molecular dynamics simulations were used to evaluate the strength of binding between shikonin and key targets, as well as the hydrogen bonds involved.  \nResults: In total, 481 targets were screened for shikonin, and 10,058 targets were identiﬁed for oral cancer. By GO and KEGG analysis, the targets of shikonin and oral cancer may be involved in the mediation of apoptosis, inﬂammation and immune response. And the associated signalling pathways that targets may be involved in the treatment of oral cancer, including the FoxO signalling pathway, HIF-1 signalling pathway, TNF signalling pathway, and Th17 cell differentiation, etc. Cytoscape software screened the key genes including AKT1, MAPK1, CXCR4, CXCL8, CCL3, CCL4, CCL5, CYBB, BCL2, NOX1, HIF-1, TP53 . The results of molecular docking and molecular dynamics simulations showed that shikonin exhibits good binding interactions with CCL3, AKT1 and NOX1 .  \nConclusions: Mulitple molecular mechanisms involved in oral cancer management with shikonin have been elucidated providing a glimpse og the underlying therapeutic targets for the disease..  \n􀀁 2025 The Authors. Published by Elsevier Inc. on behalf ofFDI World Dental Federation. This is an open access article under the CC BY-NC-ND license  \n([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/))  \n* Corresponding authors. School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin, 301617, China; Department of Stomatology, Harbin the First Hospital, Harbin, Heilongjiang Province 150010, China.  \nE-mail addresses: [guolin1996@stu.tjutcm.edu.cn](guolin1996@stu.tjutcm.edu.cn) (L. Guo), [yayizhaoqingliang@hrbsdyyy.org.cn](yayizhaoqingliang@hrbsdyyy.org.cn) (Q. Zhao).  \nQingliang Zhao: [http://orcid.org/0009-0001-0980-7201](http://orcid.org/0009-0001-0980-7201)  \ny Lin Hou and Kun Wang contributed equally to this work and should be considered co-ﬁrst authors.  \n[https://doi.org/10.1016/j.identj.2025.103954](https://doi.org/10.1016/j.identj","cbCaiqw9bpUtBH8g","https://ap.wps.com/l/cbCaiqw9bpUtBH8g","pdf",2205978,13,"English","# Article history\n# Key words\n# Abstract\n## Objectives\n## Materials and methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the objective of the study on shikonin and oral cancer?\",\"answer\":\"The study aims to explore how shikonin treats oral cancer by identifying its underlying mechanisms using network pharmacology and molecular docking.\"},{\"question\":\"How were targets for shikonin and oral cancer collected and analyzed?\",\"answer\":\"Shikonin targets were retrieved from TCMSP, BATMAN, ChEMBL, PharmMapper and HERB, while oral cancer targets were gathered from OMIM, STITCH, GeneCards and Drugbank. Intersecting targets were then used for DAVID GO/KEGG enrichment and STRING/Cytoscape analyses.\"},{\"question\":\"Which biological processes and pathways are suggested by the enrichment and network results?\",\"answer\":\"GO/KEGG results suggest involvement in apoptosis, inflammation and immune responses, with related pathways including FoxO, HIF-1, TNF signaling and Th17 cell differentiation.\"},{\"question\":\"What do docking and molecular dynamics results indicate about shikonin binding?\",\"answer\":\"Docking and molecular dynamics simulations show favorable binding interactions between shikonin and key targets, including CCL3, AKT1 and NOX1.\"}]","Exploring the Mechanism of Oral Cancer With Shikonin - Network Pharmacology and Molecular Docking Technology | PDF",1790061312,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9ced90da39c557ebc852d9bb81a87e2.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ac9a0d38017d704aa30e29dd65fe072.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6576e7804f9dbf57f830beddd90ce4bd.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd6ea9acab49fb2bc2bde6fa5ffb7cb9.webp",980,1306]